20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies

Go back to 20/20 BioLabs Highlights Advantages of its Patented Protein Biomarker Technology for Multi-Cancer Early Detection in Light of Recent Studies
(NASDAQ: AIDX) Delayed: 0.56 -0.04 (6.67%)
Previous Close $0.60    52 Week High
Open $0.57    52 Week Low
Day High $0.58    P/E N/A 
Day Low $0.55    EPS
Volume 54,856       

(NASDAQ: AIDX) Delayed: 0.56 -0.04 (6.67%)
Previous Close $0.60    52 Week High
Open $0.57    52 Week Low
Day High $0.58    P/E N/A 
Day Low $0.55    EPS
Volume 54,856